Prothena Corp Public (PRTA) Revenue (2013 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Revenue of $51.1 million in Q1 2026, up 243157.14% quarter-over-quarter from $21000.0 in Q4 2025, and up 1706.36% on a YoY basis from $2.8 million in Q1 2025.
Prothena Corp Public (PRTA) Revenue (2013 - 2026) Analysis & Trends
Prothena Corp Public's Revenue history runs 14 years deep, the most recent figure standing at $51.1 million for Q1 2026.
- In Q1 2026, Revenue rose 1706.36% year-over-year to $51.1 million; the TTM figure through Mar 2026 stood at $57.9 million (down 57.99% YoY), while the FY2025 annual figure was $9.7 million, down 92.83% from the prior year.
- Revenue was $51.1 million for Q1 2026 at Prothena Corp Public, up from $21000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $132.0 million in Q2 2024 to a low of $21000.0 in Q4 2025.
- Historically, Revenue has averaged $20.1 million across 5 years, with a median of $2.2 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Revenue tumbled 99.37% in 2023, then surged 5556.0% in 2025.
- A 5-year view of Revenue shows it stood at $49.9 million in 2022, then sank by 99.37% to $316000.0 in 2023, then soared by 571.84% to $2.1 million in 2024, then tumbled by 99.01% to $21000.0 in 2025, then jumped by 243157.14% to $51.1 million in 2026.
- The last three Revenue figures came in at $51.1 million (Q1 2026), $21000.0 (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 51.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.08 Mn |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 4.42 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 970,000.00 |
| Jun 30, 2024 | 132.01 Mn |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 84.87 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 49.92 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 139.17 Mn |
| Jun 30, 2021 | 60.07 Mn |